MOUNTAINSIDE, NJ, April 4, 2016; PRNewswire — Androvia LifeSciences, focused on male fertility, today reported results of four new studies that use its proprietary technology to quantify the ability of sperm to fertilize. The Cap-ScoreTM Sperm Function Test offers a ranking where the fertilizing ability of a semen sample is compared to that from a population of fertile men and could potentially have implications for the management of human infertility.